Irl Hirsch
Endocrinology, Diabetes & Metabolism · Seattle, WANPI 1881770642
Payments from drug & device makers
Across 398 payments — averaging $6014.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$872K
- Insulet Corporation$567K
- Tandem Diabetes Care, Inc.$439K
- Mannkind Corporation$174K
- Sequel Med Tech, LLC$106K
- Abbott$85K
- plus $151K from 13 others
Across 3 payments — averaging $79.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dexcom, Inc.$237
What the payments were for
- Consulting fees$99,64352%
- Speaking & faculty fees$31,42516%
- Travel & lodging$53,79228%
- Food & beverage$7,1094%
- Gifts$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 45 | $872,403 |
| Insulet Corporation | 18 | $566,597 |
| Tandem Diabetes Care, Inc. | 3 | $439,174 |
| Mannkind Corporation | 28 | $174,095 |
| Sequel Med Tech, LLC | 97 | $105,610 |
| Abbott | 137 | $85,029 |
| Roche Diabetes Care GmbH | 19 | $39,273 |
| Gilead | 4 | $29,236 |
| Sanofi US Services Inc. | 3 | $25,470 |
| F. Hoffmann-la Roche AG | 10 | $14,642 |
| Embecta Corp. | 4 | $13,267 |
| Lifescan, Inc. | 9 | $13,168 |
| Roche Diabetes Care, Inc. | 2 | $9,552 |
| Vertex | 12 | $5,849 |
| Dexcom, Inc. | 3 | $183 |
| Roche Diagnostics Corporation | 1 | $90 |
| BD | 1 | $74 |
| Genentech, Inc. | 1 | $38 |
| Lexicon Pharmaceuticals, Inc. | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Accu-Chek Inform II Instrument with RF card$35,741
- FREESTYLE LIBRE 3$30,196
- FreeStyle Libre Pro$21,403
- FreeStyle Libre$20,036
- DC ACCU-CHEK Diabetes Management Solutions, Cables, Software, Kits and Accessori$10,436
- AFREZZA$8,487
- Accu-Chek Instruments$2,220
- InPen$2,000
- FreeStyle Lite system$136
How this compares
$2,393,788 in reported general payments places this provider in the 95th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.
See all endocrinology, diabetes & metabolism providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 47 | $94,328 |
| JardianceEmpagliflozin | 26 | $40,727 |
| MounjaroTirzepatide | 13 | $15,041 |
| Humalog Kwikpen U-100Insulin Lispro | 22 | $14,681 |
| LyumjevInsulin Lispro-Aabc | 15 | $10,674 |
| HumalogInsulin Lispro | 45 | $10,006 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $8,136 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $7,200 |
| Novolog FlexpenInsulin Aspart | 23 | $6,217 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $4,246 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $2,252 |
| Atorvastatin Calcium | 93 | $1,001 |
| Levothyroxine Sodium | 52 | $858 |
| Ezetimibe | 31 | $705 |
| Rosuvastatin Calcium | 38 | $667 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Seattle
- Frances BroylesSeattle$5.6M
- Carla GreenbaumSeattle$2.6M
- William HagopianSeattle$2.1M
- Michael SchwartzSeattle$1.3M
- Nicole EhrhardtSeattle$484K
- Jose GarciaSeattle$432K
- Kristina UtzschneiderSeattle$374K
- Mara RothSeattle$356K
- Joshua ThalerSeattle$354K
- Cheryl Pickett-GiesSeattle$290K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.